Total Visits

Views
Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma.63

Total Visits Per Month

November 2023December 2023January 2024February 2024March 2024April 2024May 2024
Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma.22102412

File Visits

Views

Top country views

Views
United States24
Canada1

Top cities views

Views
Ashburn16
Des Moines1